Lineage Cell Therapeutics, Inc. (TLV:LCTX)
Israel
· Delayed Price · Currency is ILS · Price in ILA 251.00
-11.50 (-4.38%)
Feb 20, 2025, 5:24 PM IDT
Lineage Cell Therapeutics Market Cap
Lineage Cell Therapeutics has a market cap or net worth of 550.14 million as of February 21, 2025. Its market cap has decreased by -27.95% in one year.
Market Cap
550.14M
Enterprise Value
438.38M
Revenue
32.41M
Ranking
n/a
PE Ratio
n/a
Stock Price
251.00
Market Cap Chart
Since May 1, 1992, Lineage Cell Therapeutics's market cap has increased from 49.45M to 550.14M, an increase of 1,012.53%. That is a compound annual growth rate of 7.61%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 68.37B |
| Danel (Adir Yeoshua) | 2.53B |
| Kamada | 1.57B |
| Bait Bakfar | 1.09B |
| Novolog (Pharm-Up 1966) | 907.03M |
| Ilex Medical | 800.59M |
| BrainsWay | 762.81M |
| SofWave Medical | 597.96M |